A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans
Multivalent vaccines that confer protection to multiple serotypes of Dengue virus have been established. Here the authors examine the presence of vaccine induced multivalent antibodies and how these link to protection in a human challenge model of Dengue virus.
Guardado en:
Autores principales: | Usha K. Nivarthi, Jesica Swanstrom, Matthew J. Delacruz, Bhumi Patel, Anna P. Durbin, Steve S. Whitehead, Beth D. Kirkpatrick, Kristen K. Pierce, Sean A. Diehl, Leah Katzelnick, Ralph S. Baric, Aravinda M. de Silva |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3754cf1077b043a0a2eef363edc7666d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model
por: John P. Hanley, et al.
Publicado: (2021) -
Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes
por: Daniela V. Andrade, et al.
Publicado: (2017) -
Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone
por: Emily N. Gallichotte, et al.
Publicado: (2017) -
A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
por: E. N. Gallichotte, et al.
Publicado: (2015) -
Virus-like particles with FLAG-tagged envelope protein as a tetravalent dengue vaccine candidate
por: Toshifumi Imagawa, et al.
Publicado: (2021)